China Contrast Media Injectors Market To Reach $149.3 Million By 2030

China Contrast Media Injectors Market Growth & Trends

The China contrast media injectors market size is anticipated to reach USD 149.3 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 9.7% from 2024 to 2030. It encompasses a range of products and services for administering contrast media agents in various imaging modalities.

The China market for contrast media injectors is experiencing significant growth driven by a combination of factors. One of the primary factors contributing to the growth is the increasing prevalence of chronic illnesses such as cancer, cardiovascular diseases, and diabetes.

Rising healthcare spending in China is creating a favorable environment for growth in the contrast media injectors market. The Chinese government invests in healthcare infrastructure to enhance public health services, with healthcare expenditures reaching approximately USD 1 trillion. This increase is driven by policy reforms aimed at expanding access to quality care. Such investments support technological advancements and encourage hospitals and clinics to acquire modern medical devices, including contrast media injectors, which improve diagnostic capabilities and overall patient care.

 Request a free sample copy or view report summary: China Contrast Media Injectors Market Report

China Contrast Media Injectors Market Report Highlights

• Based on product, the injector systems segment commands the most significant revenue share of 60.8% in 2023. This dominance is primarily attributed to several important factors. The rising incidence of chronic illnesses such as cancer and cardiovascular diseases drives the demand for sophisticated imaging methods, which heavily depend on contrast media to ensure precise diagnoses.

• Based on type, the single-head injectors segment dominates the market, accounting for 43.8% of revenue. Their user-friendly design and operational simplicity make them highly favored in medical environments, such as hospitals and diagnostic imaging centers, where efficiency is critical. These injectors provide precise control during the injection process, which is essential for accurate imaging in procedures such as CT scans and MRIs. For instance, the Illumena Néo injector from Guerbet, which supports multiple modes, including ANGIO-CARDIAC, ANGIO-PERIPHERAL, and CT.

• Based on application, radiology segment is dominant due to the increasing frequency of radiological procedures performed each year highlights a significant trend; for instance, the healthcare system in China experienced a substantial rise in the number of CT and MRI scans in recent years, indicating a transition towards more advanced diagnostic methods.

• Based on end use, in 2023, the hospitals segment led the market, holding a revenue share of 68.8%. This dominance is attributed to the rising incidence of chronic diseases, a growing demand for diagnostic imaging procedures, and the integration of advanced technologies.

China Contrast Media Injectors Market Segmentation

Grand View Research has segmented the China contrast media injectors market based on product, type, application, and end use:

China Contrast Media Injectors Product Outlook (Revenue, USD Million, 2018 - 2030)

• Injector systems

  • CT Injector Systems

  • MRI Injector Systems

  • Cardiovascular/Angiography Injector Systems

• Consumables

  • Syringes

  • Tubing

  • Others

China Contrast Media Injectors Type Outlook (Revenue, USD Million, 2018 - 2030)

• Single Head Injectors

• Dual Head Injectors

• Syringeless Injectors

China Contrast Media Injectors Application Outlook (Revenue, USD Million, 2018 - 2030)

• Radiology

• Interventional Cardiology

• Interventional Radiology 

China Contrast Media Injectors End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Diagnostics Centers

• Ambulatory Surgery Centers

List of Key Players in the China Contrast Media Injectors Market

• Bracco Group

• Bayer HealthCare LLC

• GE Healthcare

• Ulrich Medical

• Guerbet Group

• Medtron AG

• Nemoto Kyorindo Co., Ltd.

• Hong Kong Medi Co Limited